| || |
|- The Return On Risk, -10.3, is in the lower class, it is lower than the industrial mean|
|- All related stocks also decline. Distribution industry -1.53%|
|- Institutions and Individuals buy, Foreigners sell|
|- Turnover Rate and Price Range both proper|
|- The main shareholding group is Individuals|
On Oct. 25, Pharma Research Products (214450) declined 4.39% to 41,350 won (US$ 36.30). It had declined 19.71% through the past month. Standard deviation, the volatility index for stock price, was 1.9% over the same period of time over one month.
Compared with its close competitors within the same industry, KOSDAQ, the monthly volatility of Pharma Research Products was not so high, the earnings rate for 1 month was also the lowest with decline of stock price. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was -10.3%. As bearish stock price trend, the return-on-risk was poor, compared with its peer group. Moreover, compared with the KOSDAQ industry, the return-on-risk is below the industrial mean, -9.1, and thus it is hard to say that the industrial comparison performance was positive.
|Close Competitors||Earning rate (%)||STD (1Mo)||Return on|
|1 Mo||3 Mo||6 Mo|
|PRP(214450): 2Q(Apr ~ June) of 2016 Earnings (reported at Aug. 17. 2016) |
| ||Revenue||Operating Income||Net Income|
|2Q of 2016||120.4 T||41.4 T||46.6 T|
|Previous Quarter||1.9% increase||13.7% increase||12.6% increase|
|YoY||43.0% increase||6.4% increase||53.8% increase|
Institutions and Individuals buy, Foreigners sell
Institutions have been buying for the past 3 trading days and foreigners have been buying for the past 2 trading days. As a shareholding sum by investor group for the past 4 weeks, institutions have bought 7,103 shares with trending trade and individuals have bought 2,890 shares lessening its position. However, during the same period, foreigners have sold 9,993 shares.
|Cumulated shareholdings per investor group (1Mo)|| ||Total shareholdings per investor group|
|* Other Investor groups, included as "other corporations", are considered as "Individuals".|
By HeRo (firstname.lastname@example.org)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp.